Matrine Enhances the Antitumor Efficacy of Chidamide in CTCL by Promoting Apoptosis

CONCLUSION: Our data have demonstrated chidamide combined with matrine to exhibit elevated antitumor activity in both CTCL cells and xenograft models of NOD/SCID mice, which may be a potential treatment option for CTCL.PMID:38571359 | DOI:10.2174/0115748928289036240318040756
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Authors: Source Type: research